Latest Biotech News

Merck secured FDA approval for Keytruda Qlex, an injectable formulation of its blockbuster cancer immunotherapy Keytruda. The new injectable version shortens administration time from 30 minutes to...

Seven Starling closed an $8 million funding round led by Rethink Impact with participation from Pear VC, Zeal Capital Partners, and March of Dimes among others. The capital injection aims to scale...

PCM Trials, EmVenio Research, and Clinical Trial Service have merged branding to establish EmVenio Clinical Research, creating a unified global organization to expand clinical trial accessibility....

Researchers Han, Tang, and Lu introduced TMolNet, a novel task-aware multimodal neural network designed to enhance molecular property prediction. TMolNet integrates various molecular data...

Circadian immunologist Christoph Scheiermann detailed how night shift work causes a misalignment between biological clocks and environmental cues, increasing risks for cardiometabolic, autoimmune...

Scientists revealed a genetic mechanism that enables ants to maintain highly specific olfactory senses by silencing neighboring receptor genes, preserving odor detection accuracy. This discovery...

A landmark study led by Dias in Waste Biomass Valor explores the often-overlooked aqueous phase of bio-oil produced by biorefineries. Researchers demonstrate its potential to generate valuable...

Researchers achieved a breakthrough in producing deep-blue light-emitting diodes (LEDs) using colloidal cesium lead bromide (CsPbBr3) nanoplatelets, meeting stringent Rec.2020 color standards for...

A novel continuous metabolic syndrome risk score (msRS) tailored for adolescents has been introduced and validated through confirmatory factor analysis. This dynamic metric allows more accurate...

Merck's injectable formulation of the blockbuster cancer immunotherapy Keytruda, branded Keytruda Qlex, has gained FDA approval. This new injectable form can be administered in minutes,...

Seven Starling, a digital maternal mental health company, secured $8 million in a funding round led by Rethink Impact, with participation from Pear VC, Zeal Capital Partners, and others including...

Agentic artificial intelligence systems are gaining ground in healthcare applications but raise significant concerns around liability and patient safety. Legal expert Lily Li, founder of Metaverse...

Researchers led by Han, Tang, and Lu have introduced TMolNet, a novel task-aware multimodal neural network designed to improve accuracy in predicting molecular properties. This machine learning...

Innovations in immunotherapy, including chimeric antigen receptor T-cell (CAR T-cell) and tumor-infiltrating lymphocyte (TIL) therapies, are emerging as promising treatments for gastrointestinal...

Studies increasingly confirm that night shift work disrupts circadian rhythms, leading to a host of adverse health outcomes including cardiometabolic, autoimmune disorders, and certain cancers....

Researchers have uncovered that ants maintain exceptional olfactory clarity through a genetic mechanism that silences neighboring receptor genes, preventing cross-activation. This discovery...

Bisabolol, a naturally occurring sesquiterpene alcohol, demonstrates selective cytotoxicity against various cancer cell lines, revealing its multifaceted potential as an anticancer agent....

A recent investigation in the Journal of Medical Biology Engineering exposes concerning associations between abdominal and pelvic CT scans in children and heightened risks for malignancies and...

Giovanni Marco Saladino, a postdoctoral scholar at Stanford University, is developing innovative multimodal nanoparticles that enable simultaneous imaging via MRI and X-ray fluorescence. These...

The FDA has granted approval to Stealth Therapeutics' therapy targeting Barth syndrome, marking the first mitochondria-targeted treatment available for this rare genetic disorder. This regulatory...